Eileen L. Heinrich, Ph.D.
Affiliations: | 2011 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular Biology, OncologyGoogle:
"Eileen Heinrich"Parents
Sign in to add mentor| Steven M. Dubinett | grad student | 2011 | UCLA | |
| (IL-1beta downregulates E-cadherin in non-small cell lung cancer via Fra-1 activation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li R, Ong SL, Tran LM, et al. (2020) Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. 10: 4386 |
| Li R, Ong SL, Tran LM, et al. (2020) Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. 10: 377 |
| Lee S, Heinrich EL, Lu J, et al. (2015) Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells. Pancreas |
| Lee S, Heinrich EL, Li L, et al. (2015) CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist. Molecular Oncology |
| Luu C, Heinrich EL, Duldulao M, et al. (2013) TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells. Plos One. 8: e70604 |
| Heinrich EL, Arrington AK, Ko ME, et al. (2013) Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 241-5 |
| Heinrich EL, Lu J, Lee W, et al. (2013) Abstract 4009: CCL25-CCR9 axis mediates pancreatic cancer progression through beta-catenin activation. Cancer Research. 73: 4009-4009 |
| Arrington AK, Heinrich EL, Lee W, et al. (2012) Prognostic and predictive roles of KRAS mutation in colorectal cancer. International Journal of Molecular Sciences. 13: 12153-68 |
| Heinrich EL, Lee W, Lu J, et al. (2012) Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. Journal of Translational Medicine. 10: 68 |
| Kim J, Yip ML, Shen X, et al. (2012) Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells. Plos One. 7: e31004 |